Improving Vaccine Protection Against Chagas Disease
Author Information
Author(s): Eickhoff Christopher S., Vasconcelos Jose R., Sullivan Nicole L., Blazevic Azra, Bruna-Romero Oscar, Rodrigues Mauricio M., Hoft Daniel F.
Primary Institution: Saint Louis University
Hypothesis
Can the co-administration of a plasmid encoding IL-15 improve long-term protection from a genetic vaccine against Trypanosoma cruzi?
Conclusion
The addition of IL-15 during genetic vaccination greatly improved long-term T cell survival and protection against T. cruzi.
Supporting Evidence
- Mice vaccinated with both pTS and pIL-15 showed significantly better protection against lethal T. cruzi challenges.
- The addition of pIL-15 did not significantly alter T cell responses during the early post-vaccination period.
- Higher numbers of TS-specific IFN-γ producing T cells were detected in mice vaccinated with pTS + pIL-15 compared to pTS alone.
Takeaway
Researchers found that adding a special ingredient called IL-15 to a vaccine helped mice stay protected from a harmful bug for a longer time.
Methodology
BALB/c mice were immunized with plasmid DNA encoding TS and/or IL-15, and immune responses were measured at various time points post-vaccination.
Limitations
The study was conducted in mice, and results may not directly translate to humans.
Participant Demographics
Female BALB/c mice, aged six to eight weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website